RESUMO

Mobile genetic elements (MGEs) are relevant agents in bacterial adaptation and evolutionary diversification. Stable appropriation of these DNA elements depends on host factors, among which are the nucleoid-associated proteins (NAPs). NAPs are highly abundant proteins that bind and bend DNA, altering its topology and folding, thus affecting all known cellular DNA processes from replication to expression. Even though NAP coding genes are found in most prokaryotic genomes, their functions in host chromosome biology and xenogeneic silencing are only known for a few NAP families. Less is known about the occurrence, abundance, and roles of MGE-encoded NAPs in foreign elements establishment and mobility. In this study, we used a combination of comparative genomics and phylogenetic strategies to gain insights into the diversity, distribution, and functional roles of NAPs within the class Acidithiobacillia with a special focus on their role in MGE biology. Acidithiobacillia class members are aerobic, chemolithoautotrophic, acidophilic sulfur-oxidizers, encompassing substantial genotypic diversity attributable to MGEs. Our search for NAP protein families (PFs) in more than 90 genomes of the different species that conform the class, revealed the presence of 1,197 proteins pertaining to 12 different NAP families, with differential occurrence and conservation across species. Pangenome-level analysis revealed 6 core NAP PFs that were highly conserved across the class, some of which also existed as variant forms of scattered occurrence, in addition to NAPs of taxa-restricted distribution. Core NAPs identified are reckoned as essential based on the conservation of genomic context and phylogenetic signals. In turn, various highly diversified NAPs pertaining to the flexible gene complement of the class, were found to be encoded in known plasmids or, larger integrated MGEs or, present in genomic loci associated with MGE-hallmark genes, pointing to their role in the stabilization/maintenance of these elements in strains and species with larger genomes. Both core and flexible NAPs identified proved valuable as markers, the former accurately recapitulating the phylogeny of the class, and the later, as seed in the bioinformatic identification of novel episomal and integrated mobile elements.

RESUMO

Resumen Objetivo: tradicionalmente, la sedación con propofol ha estado a cargo de especialistas en anestesiología; sin embargo, una extensa cantidad de información publicada ha demostrado que la sedación con propofol administrado por no anestesiólogos, es segura y eficaz. El estudio se realizó con el objetivo de evaluar la seguridad en la administración de propofol por gastroenterólogos, para la realización de procedimientos en endoscopia digestiva. Métodos: se hizo un estudio retrospectivo en el cual se revisaron los expedientes de 1135 pacientes sometidos a endoscopias digestivas diagnósticas y terapéuticas, en el período comprendido entre enero de 2016 y marzo de 2017. Los pacientes se organizaron por su: edad, género, clasificación de riesgo de la Sociedad Americana de Anestesiólogos, indicación para la endoscopia, y dosis utilizada de propofol. Se registraron los efectos adversos asociados al uso de Propofol, tales como: episodios de hipoxemia transitoria, complicaciones cardiopulmonares serias y muerte. Resultados: se incluyeron los datos de 1135 pacientes (56 % fueron mujeres) que se practicaron endoscopia digestiva bajo sedación con propofol administrado por gastroenterólogos, en un período de 14 meses. La dosis promedio utilizada de propofol fue de 154 +/- 66 mg. Según la clasificación de riesgo de la Sociedad Americana de Anestesiólogos, el 84 % de los pacientes corresponde a las clasificaciones I y II, un 14,8 % a pacientes con clasificación de riesgo III y un 1,1 %, riesgo IV. Los estudios efectuados fueron mayoritariamente gastroscopias (52,6 %) y según la indicación, el 79,6 % corresponde a estudios diagnósticos, seguido de un 12,1% para los sangrados digestivos altos de emergencia. En cuanto a las complicaciones documentadas, se identificaron 70 episodios de hipoxemia que corresponden a un 6,2 % de las sedaciones realizadas. (IC 95%, 4,7-7,6). Solamente un 3,7 % de los pacientes presentó un episodio de hipoxemia por debajo del 80 %. Todos los episodios de hipoxemia, excepto uno, resolvieron con maniobras simples, como la elevación del mentón. Durante el estudio no se presentaron complicaciones cardiopulmonares serias o muertes. Se identificaron, como factores de riesgo para la aparición de hipoxemia, una clasificación de riesgo de la Sociedad Americana de Anestesiólogos mayor a 3, y la realización del estudio endoscópico para dilatación esofágica o colocación de gastrostomía percutánea. Conclusiones: el uso de sedación con propofol administrado por no anestesiólogos en el estudio, no evidenció incremento en la aparición de complicaciones cardiopulmonares serias, ni en los episodios de hipoxemia.

Abstract Aim: Traditionally, sedation with propofol has been approved exclusively for use by anethesiologists, however, an extensive amount of published information has shown that sedation with propofol administered by non-anesthesiologists is safe and effective. The present study was conducted with the objective of evaluating the safety in the administration of propofol by gastroenterologists for the performance of procedures in digestive endoscopy. Methods: A retrospective study was conducted in which the records of 1135 patients who underwent digestive and therapeutic digestive endoscopies were reviewed in the period between January 2016 and March 2017. The patients were classified by age, gender, risk classification of the American Society of Anesthesiologists (ASA), indication for endoscopy, and dose of propofol. The adverse effects associated with the use of propofol were recorded, such as episodes of transient hypoxemia, serious cardiopulmonary complications and death. Results: We included data from 1135 patients (56% were women) who underwent gastrointestinal endoscopy under sedation with propofol administered by gastroenterologist in a period of 14 months. The average dose used for propofol was 154 +/- 66 mg of propofol. According to the American Society of Anesthesiologists risk classification, 84% of the patients correspond to risk I and II, 14.8% to risk level III and 1.1% to risk level IV. The study carried out the most were gastroscopies (52.6%) and according to the indication, 79.6% corresponded to diagnostic studies, followed by 12.1% for upper gastrointestinal bleeding. Regarding the documented complications,70 episodes of hypoxemia were identified, corresponding to 6.2% of the sedations performed. (95% CI, 4.7-7.6). Only 3.7% of patients had an episode of hypoxemia below 80%. All episodes of hypoxemia, except one, resolved with simple maneuvers such as chin elevation. There were no serious cardiopulmonary complications or deaths during the study. We identified as risk factors for the appearance of hypoxemia a risk classification of the American Society of Anesthesiologists greater than 3 and performance of the endoscopic study for esophageal dilation or percutaneous gastrostomy placement. Conclusions: The use of sedation with propofol administered by non-anesthesiologists in the present study did not show an increase in the appearance of serious cardiopulmonary complications, or in episodes of hypoxemia.

Assuntos

RESUMO

According to the United Nations, in 2017, people aged 60 or over in the world, comprised 13 per cent of the global population. It is a fact that elderly people are keeping a health lifestyle, such as practicing physical exercises and avoiding excessive dosages of medications. However, this population is also more prone to have injuries while practicing exercises. Sleep architecture is physiologically different among elderly, and naps can be very beneficial to improve their mental and physical health. Thus, in this article, we encourage health professionals to recommend regular naps to this population, which could lead to an improve in their well-being and quality of life.

Assuntos

RESUMO

Dois experimentos foram conduzidos com o objetivo de avaliar o efeito da adição de um complexo enzimático em dietas iniciais elaboradas com milho classificado ou não por mesa densimétrica sobre o desempenho produtivo e a digestibilidade de nutrientes. Foram utilizados 1080 frangos de corte, machos, distribuídos em um delineamento inteiramente ao acaso, em esquema fatorial 2 x 3 (milho classificado ou não vs. dieta controle, dieta controle acrescida de complexo enzimático e dieta controle acrescida de enzimas e com redução de 150kcal de EM), totalizando seis repetições e 36 unidades experimentais. No ensaio de metabolismo, foram utilizadas 96 aves de 21 dias de idade, alojadas em baterias metálicas e distribuídas aos seis tratamentos, com oito repetições e 48 unidades experimentais. Dietas suplementadas com enzima, independentemente da classificação do milho, resultaram em maior (P<0,05) ganho de peso das aves aos 21 dias de idade. A adição de enzimas em dietas com milho classificado melhorou (P<0,05) a conversão alimentar. O CDPB foi maior (P<0,05) para dietas elaboradas com milho classificado, independentemente da suplementação do complexo enzimático, enquanto o CDEE de dietas à base de milho não classificado aumentou (P<0,05) quando as enzimas foram incluídas na deita. Dietas elaboradas à base de milho classificado e acrescidas de complexo enzimático comercial melhoraram (P<0,05) a EMA e a EMAn. As enzimas exógenas podem ser empregadas como ferramenta para melhorar a digestibilidade de nutrientes e de energia dos grãos de milho com variação nutricional.(AU)

Two experiments were performed with the aim of evaluating the effect of inclusion of enzymatic complexes in starter diets containing classified corn or not on the productive performance of poultry and nutrient digestibility. In the performance test 1080 broilers were used, distribuited in a completely randomized design in a factorial 2 x 3 (classified corn or not and corn control diet, control diet plus enzyme complex, and control diet plus enzymes and reduction of 150kcal of ME) and consisting of six replicates and 36 experimental units. In the metabolism trial 96 21-day-old birds were used, housed in metal cages, distributed to six treatments with eight replicates of 48 experimental units. Diets supplemented with enzyme, regardless of the corn classification, resulted in higher (P<0.05) weight gain of birds at 21 days of age. The addition of enzymes in diets with classified corn improved (P<0.05) feed conversion ratio. The CDPB was higher (P<0.05) for diets formulated with classified corn, regardless of the supplementation of the enzyme complex, while the CDEE of not classified corn-based diets increased (P<0.05) when the enzymes were included. Diets formulated with classified corn plus commercial enzymatic complex, improved (P < 0.05) the AME and AMEn. Exogenous enzymes may be employed as a tool to improve the digestibility of nutrients and energy of corn with nutritional variation.(AU)

Assuntos

RESUMO

Dois experimentos foram conduzidos com o objetivo de avaliar o efeito da adição de um complexo enzimático em dietas iniciais elaboradas com milho classificado ou não por mesa densimétrica sobre o desempenho produtivo e a digestibilidade de nutrientes. Foram utilizados 1080 frangos de corte, machos, distribuídos em um delineamento inteiramente ao acaso, em esquema fatorial 2 x 3 (milho classificado ou não vs. dieta controle, dieta controle acrescida de complexo enzimático e dieta controle acrescida de enzimas e com redução de 150kcal de EM), totalizando seis repetições e 36 unidades experimentais. No ensaio de metabolismo, foram utilizadas 96 aves de 21 dias de idade, alojadas em baterias metálicas e distribuídas aos seis tratamentos, com oito repetições e 48 unidades experimentais. Dietas suplementadas com enzima, independentemente da classificação do milho, resultaram em maior (P<0,05) ganho de peso das aves aos 21 dias de idade. A adição de enzimas em dietas com milho classificado melhorou (P<0,05) a conversão alimentar. O CDPB foi maior (P<0,05) para dietas elaboradas com milho classificado, independentemente da suplementação do complexo enzimático, enquanto o CDEE de dietas à base de milho não classificado aumentou (P<0,05) quando as enzimas foram incluídas na deita. Dietas elaboradas à base de milho classificado e acrescidas de complexo enzimático comercial melhoraram (P<0,05) a EMA e a EMAn. As enzimas exógenas podem ser empregadas como ferramenta para melhorar a digestibilidade de nutrientes e de energia dos grãos de milho com variação nutricional.(AU)

Two experiments were performed with the aim of evaluating the effect of inclusion of enzymatic complexes in starter diets containing classified corn or not on the productive performance of poultry and nutrient digestibility. In the performance test 1080 broilers were used, distribuited in a completely randomized design in a factorial 2 x 3 (classified corn or not and corn control diet, control diet plus enzyme complex, and control diet plus enzymes and reduction of 150kcal of ME) and consisting of six replicates and 36 experimental units. In the metabolism trial 96 21-day-old birds were used, housed in metal cages, distributed to six treatments with eight replicates of 48 experimental units. Diets supplemented with enzyme, regardless of the corn classification, resulted in higher (P<0.05) weight gain of birds at 21 days of age. The addition of enzymes in diets with classified corn improved (P<0.05) feed conversion ratio. The CDPB was higher (P<0.05) for diets formulated with classified corn, regardless of the supplementation of the enzyme complex, while the CDEE of not classified corn-based diets increased (P<0.05) when the enzymes were included. Diets formulated with classified corn plus commercial enzymatic complex, improved (P 0.05) the AME and AMEn. Exogenous enzymes may be employed as a tool to improve the digestibility of nutrients and energy of corn with nutritional variation.(AU)

Assuntos

RESUMO

STUDY OBJECTIVES: To assess whether daytime naps negatively impact nocturnal sleep. DESIGN: Longitudinal, prospective cohort design. PARTICIPANTS: 161 pregnant women recruited and evaluated in early gestation (10-20 weeks). MEASUREMENTS AND RESULTS: Daily sleep information was collected in three 2-week periods (10-12, 14-16, and 18-20 weeks gestation) with a daily sleep diary and an actigraph. The average number of naps, as well as the average length of each nap, were calculated from sleep diaries. Women were categorized first as non nappers (0 naps/2-week period), moderate nappers (1-3 naps/2-week period), or frequent nappers (≥ 4 naps/2-week period). Then, based on the average nap length, they were categorized as short (< 90 min) or long (≥ 90 min) nappers. Nocturnal sleep parameters included SOL, WASO, SE, and TST. SAS procedure MIXED was used for modeling the main effects of nap group and time, and time by nap group interactions. Women who took naps had a decrease in diary-assessed nocturnal TST, but not actigraphy-assessed TST. This observation was group- and time-specific. There were no other group differences. Women who napped ≥ 90 min had poorer diary-assessed SE and lower diary-assessed TST than those who took shorter naps. Length of nap was not associated with any other sleep measures. CONCLUSIONS: The number of daytime naps have minimal impact on nocturnal sleep parameters; however, long nappers did exhibit modestly impaired sleep continuity and sleep quality. Overall, we propose that daytime naps provide a beneficial countermeasure to the sleep disruption commonly reported by pregnant women. This may be clinically beneficial given that sleep continuity and quality are important correlates of pregnancy outcomes. COMMENTARY: A commentary on this article appears in this issue on page 593.

Assuntos